Revenio stock surges on Q1 sales beat
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Revenio Group Corporation (REG1V)
Revenio Group Corporation stock price live, this page displays HE REG1V stock exchange data. View the REG1V premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Revenio Group Corporation real time stock price chart below.
What Is the Revenio Group Corporation Stock Price Today?
The Revenio Group Corporation stock price today is 24.35.
What Is the Stock Symbol for Revenio Group Corporation?
The stock symbol for Revenio Group Corporation is ""REG1V.""
What Stock Exchange Does Revenio Group Corporation Trade On?
Revenio Group Corporation is listed and trades on the Helsinki stock exchange.
Is Revenio Group Corporation a Good Stock to Buy?
Determining whether Revenio Group Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the REG1V quote. (ISIN: FI0009010912)
What Is the Revenio Group Corporation Stock Price Today?
The Revenio Group Corporation stock price today is 24.35.
What Is the Stock Symbol for Revenio Group Corporation?
The stock symbol for Revenio Group Corporation is ""REG1V.""
What Stock Exchange Does Revenio Group Corporation Trade On?
Revenio Group Corporation is listed and trades on the Helsinki stock exchange.
Is Revenio Group Corporation a Good Stock to Buy?
Determining whether Revenio Group Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the REG1V quote. (ISIN: FI0009010912)
Helsinki
Currency in EUR
24.35
-0.25(-1.02%)
Closed·
Fair Value
An estimate of a Revenio Group's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.15
24.85
52 wk Range
21.35
35.84
REG1V Scorecard
Full Analysis
Has raised its dividend for 6 consecutive years
REG1V is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Revenio Group's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.1524.85
52 wk Range
21.3535.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
REG1V Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Revenio Group's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
29.96
Upside
+23.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Revenio Group Oyj receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Revenio Group shares tumble on Q4 sales miss
- Investing.com
- Revenio stock surges on Q1 sales beat
- Investing.com
- Revenio Group shares tumble on Q4 sales miss
- Investing.com
- Revenio Group Oyj receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Revenio Group Corporation Company Profile
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Compare REG1V to Peers and Sector
Metrics to compare | REG1V | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipREG1VPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.1x | 26.6x | −0.5x | |
PEG Ratio | 13.77 | 0.82 | 0.00 | |
Price/Book | 5.8x | 2.1x | 2.6x | |
Price / LTM Sales | 6.1x | 1.7x | 3.3x | |
Upside (Analyst Target) | 22.8% | 28.8% | 43.4% | |
Fair Value Upside | Unlock | 8.6% | 7.1% | Unlock |
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 29.96
(+23.04% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
0.13 / 0.1933
Revenue / Forecast
26.50M / 27.83M
People Also Watch
FAQ
What Stock Exchange Does Revenio Group Trade On?
Revenio Group is listed and trades on the Helsinki Stock Exchange stock exchange.
What Is the Stock Symbol for Revenio Group?
The stock symbol for Revenio Group is "REG1V."
What Is the Revenio Group Market Cap?
As of today, Revenio Group market cap is 647.79M.
What Is Revenio Group's Earnings Per Share (TTM)?
The Revenio Group EPS (TTM) is 0.68.
When Is the Next Revenio Group Earnings Date?
Revenio Group will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is REG1V a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Revenio Group Stock Split?
Revenio Group has split 4 times.
How Many Employees Does Revenio Group Have?
Revenio Group has 246 employees.
What is the current trading status of Revenio Group (REG1V)?
As of 08 Aug 2025, Revenio Group (REG1V) is trading at a price of 24.35, with a previous close of 24.60. The stock has fluctuated within a day range of 24.15 to 24.85, while its 52-week range spans from 21.35 to 35.84.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.